Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bioxcel Therapeutics Inc
(NQ:
BTAI
)
0.5399
-0.0001 (-0.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bioxcel Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
February 08, 2024
Via
Benzinga
AI-Focused Drug Discovery Stocks Index Up 26% In December
December 29, 2023
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.
Via
Talk Markets
AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week
December 17, 2023
A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Long Term Investor Notice: Investigation of Potential Wrongdoing
December 08, 2023
San Diego, CA -- (SBWIRE) -- 12/08/2023 -- An investigation on behalf of current long-term investors in shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI) concerning potential breaches of fiduciary...
Via
SBWire
Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November
December 06, 2023
The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Expert Ratings for BioXcel Therapeutics
November 15, 2023
Via
Benzinga
Recap: BioXcel Therapeutics Q3 Earnings
November 14, 2023
Via
Benzinga
Earnings Outlook For BioXcel Therapeutics
November 13, 2023
Via
Benzinga
Unlocking AI investment opportunities in healthcare
November 16, 2023
AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Exposures
Artificial Intelligence
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 14, 2023
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.
Via
Benzinga
Where BioXcel Therapeutics Stands With Analysts
September 08, 2023
Via
Benzinga
Why Is Dementia Focused BioXcel Therapeutics Stock Trading Lower Today?
November 14, 2023
BioXcel Therapeutics Inc (NASDAQ: BTAI) announced alignment with the FDA's recommendation for a Phase 3 trial in the TRANQUILITY program of BXCL501 for acute treatment of agitation associated
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 14, 2023
Via
Benzinga
BioXcel Therapeutics Reveals Survival Data From Prostate Cancer Combo Therapy Trial
November 08, 2023
BioXcel Therapeutics Inc (NASDAQ: BTAI) announced overall survival (OS) data from its Phase 2 trial of BXCL701 in combination with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) in patients wi
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 30, 2023
Via
Benzinga
Dow Falls Over 100 Points; Alphabet Shares Tumble After Q3 Results
October 25, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Wednesday. The Dow traded down 0.35% to 33,025.71 while the NASDAQ fell 2.45% to 12,817.76....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 25, 2023
Via
Benzinga
BioXcel Therapeutics Inc. (NASDAQ: BTAI) Leading the Way in Wednesday Trading Based on Percentage Gain
October 25, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Shell Layoffs 2023: What to Know About the Latest SHEL Job Cuts
October 25, 2023
Shell layoffs are on the horizon as the petrol company prepares to cut 200 jobs in 2024 with another 130 jobs under review.
Via
InvestorPlace
Topics
Energy
Workforce
Exposures
Fossil Fuels
Layoff
EVGO Stock Slips as TD Cowen Downgrades EVgo
October 25, 2023
EVgo stock is taking a beating on Wednesday as investors in the EV charging company deal with a downgrade and price cut.
Via
InvestorPlace
Nasdaq Down 1.5%; Microsoft Posts Upbeat Results
October 25, 2023
U.S. stocks traded lower this morning, with the Nasdaq Composite falling 1.5% on Wednesday. Following the market opening Wednesday, the Dow traded down 0.26% to 33,053.68 while the NASDAQ fell 1.50% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is BioXcel Therapeutics (BTAI) Stock Up 42% Today?
October 25, 2023
BioXcel Therapeutics stock is rising on Wednesday as investors in BTAI stock react to results from an audit on a clinical trial.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 25, 2023
Via
Benzinga
BIOXCEL ALERT: Bragar Eagel & Squire, P.C. is Investigating BioXcel Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
October 11, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Schizophrenia Player BioXcel's Drug Faces Funding Headwinds, Analyst Downgrades Stock
October 05, 2023
Truist downgraded BioXcel Therapeutics Inc (NASDAQ: BTAI) from Buy to Hold, citing significant near-term funding and
Via
Benzinga
Why Shares of BioXcel Therapeutics Fell This Week
September 28, 2023
The company's co-founder is leaving, and layoffs are coming.
Via
The Motley Fool
Topics
Workforce
Exposures
Layoff
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
October 05, 2023
Via
Benzinga
NASDAQ: BTAI Investor Alert: Deadline on September 5, 2023 in Lawsuit Against BioXcel Therapeutics, Inc.
September 05, 2023
San Diego, CA -- (SBWIRE) -- 09/05/2023 -- The Shareholders Foundation announced that a deadline is coming up on September 5, 2023 in the lawsuit filed for certain investors of BioXcel Therapeutics,...
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
BTAI DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important September 5 Deadline in Securities Class Action – BTAI
September 04, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.